Search

Search Results
Results 14011 - 14020 of 17237 for Active treatment
  • Drug - 16 Apr 2026
    Consumer Medicine Information (CMI) about Fabrazyme intended for persons living in Australia.
  • Drug - 15 Apr 2026
    Consumer Medicine Information (CMI) about Qdenga intended for persons living in Australia.
  • News - 10 Apr 2026
    New research from the University of Maryland, Baltimore County (UMBC) reveals how two different parts of the brain's memory center team up in a key reward region to help mice-and likely humans-combine...
  • Drug - 10 Apr 2026
    Consumer Medicine Information (CMI) about Caprelsa intended for persons living in Australia.
  • News - 9 Apr 2026
    Higher optimism in adults aged 70 and older was associated with a lower risk of developing dementia over up to 14 years of follow-up in the Health and Retirement Study. The association remained after...
  • Drug - 8 Apr 2026
    Consumer Medicine Information (CMI) about Jardiamet intended for persons living in Australia.
  • News - 2 Apr 2026
    This week, the Centers for Diseases Control and Prevention posted online its first large tranche of advanced genetic data from measles viruses spreading last year.
  • Drug - 2 Apr 2026
    Consumer Medicine Information (CMI) about Tegretol intended for persons living in Australia.
  • Drug - 2 Apr 2026
    Consumer Medicine Information (CMI) about Avloire intended for persons living in Australia.
  • Drug - 2 Apr 2026
    Consumer Medicine Information (CMI) about Nitrostat intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.